Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Epiris announces the sale of Audiotonix

3 Feb 2017 07:00

RNS Number : 9334V
Electra Private Equity PLC
03 February 2017
 

PRESS RELEASE

3 February 2017

 

 

Epiris announces the sale of Audiotonix

 

Epiris is pleased to announce that it has agreed the sale of Audiotonix, a leading manufacturer of audio mixing consoles, to Astorg, a leading European private equity firm. The transaction is anticipated to close in the first quarter of 2017, subject to regulatory approvals.

 

Electra Private Equity PLC ("Electra") is expected to receive proceeds from the sale of £203 million, an uplift of £62 million or 44% and equivalent to an increase in its NAV of 133 pence per share on the valuation of the investment at 30 September 2016. This equates to a return of 4.8x original cost* and an IRR of 51%, assuming completion by the end of March.

 

Audiotonix is the global market leader in the design and manufacture of audio mixing consoles for live events and broadcast sound. Its three premium brands (Allen & Heath, Calrec and DiGiCo) support live sound for a variety of purposes such as concerts, TV broadcasting, theatre shows and major international live events.

 

Epiris initially invested £42 million on Electra's behalf in the acquisition of Allen & Heath in 2013. This was followed by the acquisition of Calrec in March 2014 and a merger with DiGiCo in August of that year to form Audiotonix. Epiris had identified both Calrec and DiGiCo as add-on opportunities prior to investing in Allen & Heath. These three transactions have created a market leader with a strong growth profile.

 

Charles Elkington, Partner at Epiris, said:

 

"This has been a fantastic deal for Epiris and its investors, and clearly demonstrates our strategy in action.

 

"Through structured investment across three valuable brands we have created a global market leader with strong growth prospects. When we made the initial investment we had a clear strategy based on M&A, operational improvement and strategic focus. We have delivered this with two add-on acquisitions, a reorganised supply chain, and successful investment in sales and marketing as well as new product development. As a result the business has more than quadrupled earnings since 2013.

 

"The management team, under James Gordon's passionate and insightful leadership, is exceptional and we wish them all the best for the future."

 

James Gordon, CEO of Audiotonix, said:

 

"Epiris have been an extremely supportive and engaged partner. Their vision and leadership in combining the three businesses and subsequent contribution to the evolution of the group has been invaluable. We now have a solid foundation from which to push into the next stage of our development."

 

Charles Elkington and Ian Wood are responsible for the investment and the exit of Audiotonix. Robert W. Baird advised on the sale with Taylor Wessing providing legal advice.

 

Epiris refers to Epiris Managers LLP acting on behalf of its client Electra Private Equity PLC.

 

Ends 

 

 

 

For further information please contact:

Andrew Honnor, Matthew Goodman, Matthieu Roussellier, Greenbrook Communications +44 (0)20 7952 2000

Nicholas Board and Andrew Kenny, Epiris +44 (0)20 7306 3902

 

 

Note to Editors:

 

About Epiris

Epiris is a top-decile private equity fund manager*.

 

Epiris, together with its predecessor firms, has managed the business and affairs of Electra Private Equity PLC, a listed private equity investment trust, for four decades. Epiris has also managed private equity investment programmes for pension funds, financial institutions and family offices. During this time Epiris has invested in excess of £5 billion in over 200 deals. As at 30 September 2016, the firm had funds under management of

£2.4 billion.

 

Epiris' flexible investment strategy has allowed it to invest broadly across the private equity market, including in buyouts and co-investments, secondaries and debt assets.

 

In respect of buyouts and co-investments and loan-to-own debt investments made since 2011, Epiris has delivered a gross IRR of 37%**.

 

For further information please visit www.epiris.co.uk.

 

Issued by Epiris Managers LLP which is authorised and regulated by the Financial Conduct Authority.

 

* Refers to the 2009 and 2012 investment pools comprising Buyout & Co-investment, Secondary and Debt investments managed on behalf of Electra Private Equity PLC; comparator data supplied by Preqin.

 

** As at 30 September 2016 adjusted for subsequent investments and realisations. Gross IRR does not reflect adjustments for investment management and administration costs. Past performance is no guarantee of future results.

 

About Astorg

Astorg is a European private equity firm with total funds under management of over €4 billion. Astorg seeks to partner with entrepreneurial management teams to acquire European companies and create value through the provision of strategic guidance, experienced governance and adequate capital. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body enhancing its reactivity. Though not specialized, Astorg has gathered a valuable industry expertise in healthcare, business-to-business professional services, and technology-based industrial companies. Astorg has offices in London, Paris and Luxembourg, plus Senior Advisors based in Zurich and Frankfurt.

 

For further information about Astorg, please visit www.astorg.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAFAAEDKXEAF
Date   Source Headline
16th Nov 20169:46 amRNSHolding(s) in Company
8th Nov 20167:00 amRNSPROPOSED RETURN OF UP TO £200M TO SHAREHOLDERS
14th Oct 20167:00 amRNSResult of Strategic Review - Phase I
7th Oct 20167:05 amRNSElectra Partners announces the sale of Vidal Group
4th Oct 20167:10 amRNSPartial realisation of Premier Asset Management
23rd Sep 201611:37 amRNSElectra Partners completes the sale of Elian
16th Sep 20167:08 amRNSElectra Private Equity Hollywood IPO Release
1st Sep 20165:34 pmRNSHolding(s) in Company
16th Aug 20164:14 pmRNSHolding(s) in Company
3rd Aug 20163:55 pmRNSDirector/PDMR Shareholding
3rd Aug 20163:53 pmRNSDirector/PDMR Shareholding
27th Jul 20165:23 pmRNSDirector/PDMR Shareholding
22nd Jul 20167:00 amRNSAppointment of Chief Financial Officer
19th Jul 20163:43 pmRNSDirector/PDMR Shareholding
19th Jul 201611:37 amRNSDirector/PDMR Shareholding
1st Jul 20167:00 amRNSPartial realisation of Allflex
28th Jun 20164:45 pmRNSDirector Declaration
20th Jun 20167:00 amRNSDirectorate Change
17th Jun 20164:21 pmRNSHalf-year Report
14th Jun 20167:00 amRNSCancellation of Revolving Credit Facility
6th Jun 20169:31 amRNSDirector/PDMR Shareholding
6th Jun 20167:21 amRNSElectra Partners agrees sale of Elian
2nd Jun 20163:56 pmRNSDirectorate Change
2nd Jun 20169:30 amRNSAdditional Information re Board Appointments
27th May 20169:46 amRNSDirector/PDMR Shareholding
26th May 20167:00 amRNSInterim Update on Strategic Review
4th May 20167:00 amRNSHalf-year Report
19th Apr 20167:00 amRNSDirectorate Change
4th Apr 201612:06 pmRNSDirector/PDMR Shareholding
16th Mar 20169:48 amRNSDirector/PDMR Shareholding
1st Mar 20165:47 pmRNSDirector/PDMR Shareholding
25th Feb 20166:30 pmRNSDisclosure of home member state
25th Feb 20167:00 amRNSChange of broker
10th Feb 201612:13 pmRNSDirector/PDMR Shareholding
4th Feb 20169:29 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSElectra announces the sale of Daler-Rowney
29th Jan 201611:11 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSQuarterly Update Report
26th Jan 20164:53 pmRNSHolding(s) in Company
26th Jan 201612:20 pmRNSSpecial Resolution passed at AGM - 25 January 2016
26th Jan 20167:00 amRNSResult of AGM
25th Jan 20167:00 amRNSBoard review of investment policy and structure
12th Jan 20161:56 pmRNSDirector/PDMR Shareholding
8th Jan 20162:34 pmRNSHolding(s) in Company
6th Jan 201610:27 amRNSDirector/PDMR Shareholding
4th Jan 201610:15 amRNSTotal Voting Rights
4th Jan 20169:57 amRNSHolding(s) in Company
31st Dec 201510:17 amRNSBlocklisting Interim Review
30th Dec 20153:40 pmRNSMandatory Conversion of Bonds clarification
30th Dec 201510:20 amRNSMandatory Conversion of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.